Aptevo Therapeutics Inc [NASDAQ: APVO] loss -38.00% or -0.13 points to close at $0.20 with a heavy trading volume of 8319037 shares.
The daily chart for APVO points out that the company has recorded -95.89% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 6.34M shares, APVO reached to a volume of 8319037 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aptevo Therapeutics Inc [APVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APVO shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APVO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Aptevo Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2018. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on October 05, 2017, representing the official price target for Aptevo Therapeutics Inc stock.
The Average True Range (ATR) for Aptevo Therapeutics Inc is set at 0.05 The Price to Book ratio for the last quarter was 0.19, with the Price to Cash per share for the same quarter was set at 0.86.
Trading performance analysis for APVO stock
Aptevo Therapeutics Inc [APVO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -42.37. With this latest performance, APVO shares dropped by -51.09% in over the last four-week period, additionally sinking by -95.89% over the last 6 months – not to mention a drop of -98.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APVO stock in for the last two-week period is set at 23.69, with the RSI for the last a single of trading hit 15.69, and the three-weeks RSI is set at 29.38 for Aptevo Therapeutics Inc [APVO]. The present Moving Average for the last 50 days of trading for this stock 0.3798, while it was recorded at 0.3222 for the last single week of trading, and 3.2395 for the last 200 days.
Aptevo Therapeutics Inc [APVO]: A deeper dive into fundamental analysis
Aptevo Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.77 and a Current Ratio set at 1.77.
An analysis of Institutional ownership at Aptevo Therapeutics Inc [APVO]
There are presently around $20.85%, or 20.86%% of APVO stock, in the hands of institutional investors.
